Stein Gold, L. , Eyerich, K. , Sofen, H. , Herranz, P. , Kircik, L. , Bewley, T. , Wolf, E. , Gallo, G. , Ding, Y. , Yang, F.E. , Pau-Charles, I. and Gooderham, M. 2023. Lebrikizumab Demonstrates Consistent Efficacy at 16 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis Regardless of Baseline Disease Severity. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s274. DOI:https://doi.org/10.25251/skin.7.supp.274.